Resmetirom received FDA approval for the fibrotic stage, but the steatosis stage, where the vast majority of patients sit, has no approved pharmacological intervention
"I should be one of the enthusiastic ones, but in reality, I'm one of the skeptics, or cautious at least," says Riccardo De Giorgi, psychiatrist and clinical researcher who studies mental health and GLP-1s at the University of Oxford
Macro vascular complications are still the primary cause of death in patients with T2DM.Glucagon like peptide-1 receptor agonists (GLP1-RAs) are a new class of Injectable Anti-diabetes Agents (IADA) that provides blood glucose control with weight reduction ability, systolic blood pressure reduction and a noticeable improvement of lipid profile
Wegovy (semaglutide) Wegovy is a GLP-1 agonist medication that is approved to: Aid in weight loss for adults and children over 12 years old who have obesity, or in adults who have overweight and have a weight-related health condition (such as high blood pressure, type 2 diabetes , or high cholesterol) Reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults who have cardiovascular disease and have obesity or overweight Wegovy comes in a single-use pen that you inject once per week, either with or without food
Orforglipron doesn't match tirzepatide's 20% weight loss
A registered dietitian with GLP-1 experience can help you: Manage GI symptoms Build a GLP-1-friendly kitchen and routine Optimize your macronutrient and micronutrient intake Plan nourishing meals and snacks Adding in strategic supplements for your health Stay consistent, compassionate, and confident on your journey
